Right execution should help bag good market share; firm likely to gain from push for biosimilars; ‘Buy’ retained
from The Financial Express https://ift.tt/3i1FFHs
Friday, 4 September 2020
Biocon rating: Buy — Semglee launch in the US boosts prospects
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment